Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZBTB10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
CD164 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMPR1A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM199X - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOXD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2D1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLEKHF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CWF19L1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100505817 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MAP4K3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C5orf22 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAB18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FBXO11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATG3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RAP2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ACAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on